ME3 and familial pancreatic carcinoma: Noteworthy, in pancreatic cancer, ME3 expression has been recently found higher in tumors than that in non-tumor tissues, and patients with higher ME3 levels had significantly shorter survival than those with lower levels according to the Badea and The Cancer Genome Atlas (TCGA) databases () [36].